Kepivance and lung infiltration 
Kepivance and lung infiltration Patient Reports February 09, 2010
Kepivance Side Effects Report #5393696-1
Kepivance side effect was reported by a Physician from BELGIUM on July 11, 2007. Female patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, febrile neutropenia, gastritis, hypoalbuminaemia, lung infiltration, mouth haemorrhage, oesophagitis, sepsis
. Kepivance dosage: unknown. During the same period patient was treated with LORAZEPAM, ZESTRIL, MELPHALAN, ZOFRAN, CETIRIZINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #5416686-9
Kepivance side effect was reported by a Physician from BELGIUM on Aug 07, 2007. Female patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, febrile neutropenia, gastritis, hypoalbuminaemia, lung infiltration, mouth haemorrhage, oesophagitis, sepsis
. Kepivance dosage: unknown. During the same period patient was treated with LORAZEPAM, ZESTRIL, MELPHALAN, ZOFRAN, CETIRIZINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #5469751-4
Kepivance side effect was reported by a Physician from BELGIUM on Sept 18, 2007. Female patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, febrile neutropenia, gastritis, hypoalbuminaemia, lung infiltration, mouth haemorrhage, oesophagitis, sepsis
. Kepivance dosage: unknown. During the same period patient was treated with TEMESTA, ZESTRIL, MELPHALAN, ZOFRAN, CETIRIZINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4949408-6
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: fluid retention, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, weight increased. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4949409-8
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, cardiac disorder, circulatory collapse, hypotension, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #4949410-4
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, fluid retention, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure, weight increased. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4966049-5
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4966067-7
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, circulatory collapse, hepatocellular damage, hypotension, jugular vein thrombosis, lung infiltration, mucosal inflammation, pancreatitis, pneumonia
. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE, CYCLOPHOSPHAMIDE, CEFTAZIDIME. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #4974997-5
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, clostridium colitis, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4981571-3
Kepivance side effect was reported by a Physician from GERMANY on Apr 12, 2006. Female patient, weighting 101.4 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: lung infiltration, pulmonary fibrosis
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, CIPROFLOXACIN, COTRIM DS, COTRIM DS, VALTREX. Patient died on 03/28/2006.Kepivance Side Effects Report #4993491-9
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, circulatory collapse, hypotension, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure, staphylococcal sepsis. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE, CYCLOPHOSPHAMIDE, CEFTAZIDIME. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #4993498-1
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4993499-3
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4994850-0
Kepivance side effect was reported by a Physician from GERMANY on Apr 12, 2006. Female patient, weighting 101.4 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cardiac failure, fluid overload, lung infiltration, pulmonary fibrosis
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, CIPROFLOXACIN, COTRIM DS, COTRIM DS, VALTREX, METHOTREXATE, CYCLOSPORINE, ANTITHYMOCYTE IMMUNOGLOBULIN. Patient died on 03/28/2006.Kepivance Side Effects Report #4994851-2
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #4994856-1
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.Kepivance Side Effects Report #4994862-7
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, circulatory collapse, hypotension, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure, staphylococcal sepsis. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE, CYCLOPHOSPHAMIDE, CEFTAZIDIME. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #5008300-1
Kepivance side effect was reported by a Physician from GERMANY on Apr 12, 2006. Female patient, weighting 101.4 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: lung infiltration, pulmonary fibrosis
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, CIPROFLOXACIN, COTRIM DS, COTRIM DS, VALTREX, METHOTREXATE, CYCLOSPORINE, ANTITHYMOCYTE IMMUNOGLOBULIN. Patient died on 03/28/2006.Kepivance Side Effects Report #5019926-3
Kepivance side effect was reported by a Physician from GERMANY on Apr 12, 2006. Female patient, weighting 101.4 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: condition aggravated, lung infiltration, neutropenia, pulmonary fibrosis
, respiratory failure, right ventricular failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, CIPROFLOXACIN, COTRIM DS, COTRIM DS, VALTREX, METHOTREXATE, CYCLOSPORINE, ANTITHYMOCYTE IMMUNOGLOBULIN. Patient died on 03/28/2006.Kepivance Side Effects Report #5019950-0
Kepivance side effect was reported by a Physician from GERMANY on Feb 24, 2006. Female patient, weighting 167.6 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: cytomegalovirus antigen positive, fluid retention, graft versus host disease, lung infiltration, mucosal inflammation, oedema, pneumonia
, pulmonary congestion. Kepivance dosage: unknown. During the same period patient was treated with PANTOPRAZOLE, CASPOFUNGIN, METRONIDAZOLE, CIPROFLOXACIN, ACYCLOVIR, MORPHINE, CYCLOSPORINE. Patient was hospitalized. Patient recovered.Kepivance Side Effects Report #5019953-6
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 149.9 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: capillary leak syndrome, circulatory collapse, hypotension, lung infiltration, mucosal inflammation, pneumonia
, respiratory failure, staphylococcal sepsis. Kepivance dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, PIPERACILLIN, METRONIDAZOLE, ZOVIRAX, FLUCONAZOLE, SANDIMMUNE, CYCLOPHOSPHAMIDE, CEFTAZIDIME. Patient was hospitalized. Patient died on 02/13/2006.Kepivance Side Effects Report #5019954-8
Kepivance side effect was reported by a Physician from GERMANY on Feb 16, 2006. Male patient, weighting 132.3 lb, was diagnosed with mucosal inflammation and was treated with Kepivance. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, capillary leak syndrome, clostridial infection, fluid retention, lung infiltration, lung injury, mucosal inflammation, pneumonia
, respiratory failure. Kepivance dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VALTREX, PIPERACILLIN, SANDIMMUNE, CYCLOPHOSPHAMIDE, METHOTREXATE, CASPOFUNGIN. Patient was hospitalized. Patient died on 01/29/2006.